Rani Therapeutics
RANI
RANI
38 hedge funds and large institutions have $4.58M invested in Rani Therapeutics in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 42 → 38 (-4)
13% less capital invested
Capital invested by funds: $5.23M → $4.58M (-$656K)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Holders
38
Holding in Top 10
2
Calls
$147K
Puts
$142K
Top Buyers
| 1 | +$113K | |
| 2 | +$105K | |
| 3 | +$81.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$61.2K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$56K |
Top Sellers
| 1 | -$399K | |
| 2 | -$163K | |
| 3 | -$151K | |
| 4 |
VF
Virtu Financial
New York
|
-$62K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$34.6K |
